Mereo BioPharma Group plc's website uses cookies. By continuing to browse you are agreeing to our use of cookies. Find out more about our Cookie Policy.
MREO: US$2.10MPH: 37.00GBp
Working together to inspire, innovate and improve lives
11 NOV 2019Mereo BioPharma Phase 2b ASTEROID Study - Today 8.00 AM ET / 13.00 PM GMTConference call
We continue to make strong progress in development of our product portfolio, in the hope of providing better treatment options for patients suffering from rare diseases
